Gritstone bio to Participate in 43rd Annual Cowen Healthcare Conference

EMERYVILLE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that Andrew Allen, M.D., Ph.D., Gritstone’s Co-founder, President and Chief Executive Officer will participate in the “Novel Immuno-Oncology” panel at the Cowen 43rd Annual Healthcare Conference on March 6, 2023.

Panel DetailsTitle: Novel I-O Corporate PanelDate and Time: Monday, March 6, 2023 from 9:10 to 10:10am ETLocation: Boston Marriott Copley Place, 110 Huntington Ave, Boston, MA 02116

A live webcast of the panel will be available at https://ir.gritstonebio.com/investors/events. An archived replay will be accessible for 30 days following the event.

About Gritstone bioGritstone is working to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets and have programs in viral diseases and solid tumors. Independently and with our partners, we are advancing a portfolio of product candidates with the aim of improving patient outcomes and eliminating disease. www.gritstonebio.com

Gritstone ContactsInvestors:George E. MacDougallDirector, Investor Relations & Corporate CommunicationsGritstone bio, Inc.[email protected]

Media:Dan Budwick1AB(973) 271-6085[email protected] 

You May Also Be Interested In

• embecta to Participate in Investor Events
• The FUTR Corporation Affirms Pre-Released Q2 Results with Quarter-over-Quarter Revenue up 16.5% and Record June Monthly Revenue
• Americold Successfully Closes $1.3 Billion North American Cold Storage Joint Venture with EQT